CREDOS CONSULTING LIMITED
Significant control: Charles Edward Owen (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Credos Consulting Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Credos Consulting Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CREDOS CONSULTING LIMITED is an active private limited company (company number 09780305) incorporated on 16 September 2015, registered in Haywards Heath. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £44k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 6% on the prior period (£47k).
By net assets it sits in the upper half of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
Ownership and control
- Dr Charles Edward Owen
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 September 201511 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 30 September 2027in 339 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £44k | — | — | — | — | — | 2 |
| 30 June 2024 | £47k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £43,955 at 30 June 2025
- Incorporated five or more years agoIncorporated 16 September 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 339 days
- Next accounts duein 155 days
- Accounts period endNet assets £44k · micro accounts
- Accounts period endNet assets £47k · micro accounts
- Incorporated
Similar companies in Surrey
- GLOBAL EYE TRIALS LTDHorsham · inc. Aug 2015
- HEATH RESEARCH LTDFarnham · inc. Jun 2015
- MEDSA DEVELOPMENT LTDFarnham · inc. Feb 2016
- LIMEWAY PHARMA DESIGN LIMITEDDorking · inc. Mar 2015
- INDIGO PLANET CONSULTANCY LIMITEDLingfield · inc. May 2016
- TRUSPINE TECHNOLOGIES INTERNATIONAL LIMITEDGatwick · inc. Dec 2014
All companies incorporated on 16 September 2015 · in Sept 2015.
Reminders for CREDOS CONSULTING LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.